Username Password
S&P 500: 1,351.68 Change: +0.14%

WARNER CHILCOTT PLC ORD CL A IRE (WCRX)

Overview
Price 16.38
Price Change Today -$0.05 (-0.30%)
P&P rating Rating: 2
Zacks Rank 4 - SELL
Open Price $16.31
Previous Close $16.43
Daily Range $16.05 - $16.50
52-Week Range $12.90 - $25.92
Volume 1,744,357
chart
Warner Chilcott PLC, formerly Warner Chilcott Limited, is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceutical market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of our products. The company has established strong franchises in women's healthcare and dermatology through its marketing techniques and specialty sales forces. It is an integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. Its operations are carried through its wholly-owned subsidiaries in the United States, Puerto Rico, the Republic of Ireland and Northern Ireland. The Companies franchises are comprised of complementary portfolios of established branded and development-stage products. The company is headquartered in Rockaway, New Jersey.
Other Resources for WCRX
zacks.com
Commentary
Zacks Blog: WCRX's 2012 Outlook Disappoints
January 30, 2012
Zacks Blog: Watson's Drug Fails to Get Support
January 23, 2012
Zacks Blog: Good News for Mylan
December 5, 2011
Zacks Blog: Lower Actonel Sales Hurt WCRX
November 10, 2011
Zacks Blog: Generic Threat for Warner Chilcott
October 7, 2011
Warner Chilcott PLC, formerly Warner Chilcott Limited, is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceutical market. It is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of our products. The company has established strong franchises in women's healthcare and dermatology through its marketing techniques and specialty sales forces. It is an integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. Its operations are carried through its wholly-owned subsidiaries in the United States, Puerto Rico, the Republic of Ireland and Northern Ireland. The Companies franchises are comprised of complementary portfolios of established branded and development-stage products. The company is headquartered in Rockaway, New Jersey.
 
Brokerage Analyst Recommendations
17 Brokerage Firms Covering WCRX
 
   
Strong Buy
12
Buy
2
Hold
3
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 1.44
 
WCRX Ratings:BUY  SELL  HOLD
WCRX Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

6 Buy
1 Sell
 
Free Options Trader Guide
Top Buy Analysis
BUY: WCRX Rating: 2
Company: WARNER CHILCOTT LIMITED
Points: 0.09
Start Price: $15.33
Start Date: 08/07/2008 8:56 AM
LeveneOMurray
LeveneOMurray
P&P Score: 0.45
Recs:
earnings play

Comments: 0 | Comment


Top Sell Analysis
SELL: WCRX Rating: 2
Company: WARNER CHILCOTT LIMITED
Points: 11.94
Start Price: $17.24
Start Date: 11/11/2011 10:40 AM
JDShots
JDShots
P&P Score: 0.22
Recs:
I suspect more downside, due to the current Euro crisis.

Comments: 0 | Comment

Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 01/30/12 WCRX's 2012 Outlook Disappoints - Analyst Blog 0
Zacks_Analysts
0.00 01/23/12 Watson's Drug Fails to Get Support - Analyst Blog 0
Zacks_Analysts
0.00 12/05/11 Good News for Mylan - Analyst Blog 0
Zacks_Analysts
0.00 11/10/11 Lower Actonel Sales Hurt WCRX - Analyst Blog 0
Zacks_Analysts
0.00 10/07/11 Generic Threat for Warner Chilcott - Analyst Blog 0
Zacks_Analysts
0.00 09/30/11 Relief for Warner Chilcott - Analyst Blog 0
Zacks_Analysts
0.00 08/08/11 Sales Slip at Warner Chilcott - Analyst Blog 0
Zacks_Analysts
0.00 07/18/11 Warner Chilcott Announces Arbitration Decision - Analyst Blog 0
Zacks_Analysts
0.00 06/30/11 Change in Warner Chilcott's R&D - Analyst Blog 0
Zacks_Analysts
0.00 06/29/11 Watson-Columbia Drug's NDA Accepted - Analyst Blog 0
Pages: [ 1 ]  2   3  >>
Commentary
SELL: WARNER CHILCOTT LIMITED (WCRX) Rating: 2
Start Price: $17.24
Points: +11.94
Created: 11/11/2011
I suspect more downside, due to the current Euro crisis.

Comments: 0 | Comment

Recs:
 
BUY: WARNER CHILCOTT LIMITED (WCRX) Rating: 2
Start Price: $15.33
Points: +0.09
Created: 08/07/2008
earnings play

Comments: 0 | Comment

Recs:
 
BUY: WARNER CHILCOTT LIMITED (WCRX) Rating: 2
Start Price: $22.75
Points: -48.09
Created: 09/18/2010

Comments: 0 | Comment

dmb dmb
Recs:
 
BUY: WARNER CHILCOTT LIMITED (WCRX) Rating: 2
Start Price: $26.30
Points: -59.71
Created: 02/22/2010

Comments: 0 | Comment

Recs:
 
BUY: WARNER CHILCOTT LIMITED (WCRX) Rating: 2
Start Price: $17.90
Points: -0.57
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: WARNER CHILCOTT LIMITED (WCRX) Rating: 2
Start Price: $18.89
Points: -5.37
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: WARNER CHILCOTT LIMITED (WCRX) Rating: 2
Start Price: $19.11
Points: -6.36
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
JDShots 0.22 SELL One to Three Months 11/11/2011 $17.24 $16.38
(-3.13%)
-4.99% +6.95% +11.94 view
dmb 0.25 BUY Three to Six Months 09/18/2010 $22.75 $16.38
(-3.13%)
-28.00% +20.09% -48.09
Viiking 99.96 BUY Six Months to a Year 02/22/2010 $26.30 $16.38
(-3.13%)
-37.72% +21.99% -59.71
LeveneOMurray 0.45 BUY Week or Less 08/07/2008 $15.33 $16.38
(-3.13%)
+6.85% +6.76% +0.09 view
Lembesis 33.50 BUY Six Months to a Year 01/01/2008 $17.90 $16.38
(-3.13%)
-8.49% -7.92% -0.57
Seun 72.43 BUY Six Months to a Year 01/01/2008 $18.89 $16.38
(-3.13%)
-13.29% -7.92% -5.37
JamesStock 57.55 BUY Six Months to a Year 01/01/2008 $19.11 $16.38
(-3.13%)
-14.29% -7.92% -6.36
Sponsored Links